{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:49:28Z","timestamp":1794444568979,"version":"4.9.1"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a complicated endocrine and metabolic syndrome with unclear pathogenesis. The gut microbiota sheds light on the etiology and pathophysiology of PCOS. We used Mendelian randomization (MR) studies to systematically evaluate the pathological mechanism gut microbiota causally associated with PCOS risk. A network MR analysis was performed to estimate the causal effects of gut microbiota and risk factors on PCOS, as well as the mediation effect of risk factors linking gut microbiota to PCOS. The investigation of side effects for the important gut microbiota was subsequently broadened to include phenotypes by performing Phenowide-MR analysis for a range of diseases. Genus Sellimonas id.14369 were causally associated with reduced PCOS risk (odds ratio [<jats:italic toggle=\"yes\">OR<\/jats:italic>]\u2005=\u20050.69, 95% confidence interval [CI]: 0.58\u20130.84, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20051.22\u2005\u00d7\u200510<jats:sup>-4<\/jats:sup>) after multiple testing correction. And Sellimonas retained consistent causal effect estimates after a series of sensitivity analyses. In addition, we observed an indirect effect of Sellimonas on PCOS through body mass index (BMI) using network MR (<jats:italic toggle=\"yes\">b<\/jats:italic>\u2005=\u2005\u20100.05, 95% CI: \u20100.09 to \u20100.01), with a mediated proportion of 12.82% of the total effect. Further, Phenowide-MR analyses showed that the protective effects of Sellimonas on type 2 diabetes and depression (for type 2 diabetes: <jats:italic toggle=\"yes\">OR<\/jats:italic>\u2005=\u20050.95, 95% CI: 0.90\u20130.99, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0366; for depression: <jats:italic toggle=\"yes\">OR<\/jats:italic>\u2005=\u20050.99, 95% CI: 0.98\u20131.00, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0210). We summarized that the causal path between gut microbiota and type 2 diabetes are also jointly mediated by BMI. Sellimonas may be a protective factor of PCOS, which can affect the occurrence of PCOS through BMI, supporting future studies on the importance of addressing obesity and metabolic issues in preventing and managing PCOS.<\/jats:p>","DOI":"10.1097\/md.0000000000040115","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T18:04:46Z","timestamp":1730138686000},"page":"e40115","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Exploring the causal pathway from gut microbiota to polycystic ovary syndrome: A network Mendelian randomization study"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9939-5168","authenticated-orcid":false,"given":"Xueyan","family":"Gao","sequence":"first","affiliation":[{"name":"Department of General Medicine, Geriatric Hospital of Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Geriatric Hospital of Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Geriatric Hospital of Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Geriatric Hospital of Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Geriatric Hospital of Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jama.2021.23769","article-title":"Diagnosis and treatment of polycystic ovary syndrome.","volume":"327","author":"Huddleston","year":"2022","journal-title":"JAMA"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): long-term metabolic consequences.","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metabolism"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria. Epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome.","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev. Oct"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"104492","DOI":"10.1016\/j.ebiom.2023.104492","article-title":"PPM1K-regulated impaired catabolism of branched-chain amino acids orchestrates polycystic ovary syndrome.","volume":"89","author":"Mu","year":"2023","journal-title":"EBioMedicine"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"719050","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth.","volume":"2014","author":"Rojas","year":"2014","journal-title":"Int J Reprod Med"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jaad.2013.09.014","article-title":"Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.","volume":"69","author":"Dalamaga","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00125-022-05746-x","article-title":"A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.","volume":"65","author":"Liu","year":"2022","journal-title":"Diabetologia"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.metabol.2019.02.002","article-title":"Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome.","volume":"94","author":"Wang","year":"2019","journal-title":"Metabolism"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics.","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline.","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.mayocp.2019.06.015","article-title":"Effect of metformin on microvascular endothelial function in polycystic ovary syndrome.","volume":"94","author":"Heidari","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"16058","DOI":"10.1038\/nrdp.2016.58","article-title":"Polycystic ovary syndrome.","volume":"2","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/REP-19-0197","article-title":"Mechanisms of intergenerational transmission of polycystic ovary syndrome.","volume":"159","author":"Dumesic","year":"2020","journal-title":"Reproduction"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1038\/ncomms8502","article-title":"Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.","volume":"6","author":"Hayes","year":"2015","journal-title":"Nat Commun"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.chom.2008.02.015","article-title":"Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome.","volume":"3","author":"Turnbaugh","year":"2008","journal-title":"Cell Host Microbe"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","article-title":"Estrogen\u2013gut microbiome axis: physiological and clinical implications.","volume":"103","author":"Baker","year":"2017","journal-title":"Maturitas"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tem.2018.11.001","article-title":"Sex, microbes, and polycystic ovary syndrome.","volume":"30","author":"Thackray","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fendo.2020.00628","article-title":"Correlation between fecal metabolomics and gut microbiota in obesity and polycystic ovary syndrome.","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome.","volume":"25","author":"Qi","year":"2019","journal-title":"Nat Med"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian Randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/ije\/dyu176","article-title":"Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways.","volume":"44","author":"Burgess","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","article-title":"Large-scale association analyses identify host factors influencing human gut microbiome composition.","volume":"53","author":"Kurilshikov","year":"2021","journal-title":"Nat Genet"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.","volume":"14","author":"Day","year":"2018","journal-title":"PLoS Genet"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the androgen excess and polycystic ovary syndrome society.","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/ATVBAHA.109.201020","article-title":"Genetic variants influencing circulating lipid levels and risk of coronary artery disease.","volume":"30","author":"Waterworth","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ije\/dyy101","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the radial plot and radial regression.","volume":"47","author":"Bowden","year":"2018","journal-title":"Int J Epidemiol"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation.","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"bvaa177","DOI":"10.1210\/jendso\/bvaa177","article-title":"Intersection of polycystic ovary syndrome and the gut microbiome.","volume":"5","author":"Rizk","year":"2021","journal-title":"J Endocr Soc"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3390\/nu12061622","article-title":"Impact of short-term isoflavone intervention in polycystic ovary syndrome (PCOS) patients on microbiota composition and metagenomics.","volume":"12","author":"Haudum","year":"2020","journal-title":"Nutrients"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2017-02153","article-title":"Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism.","volume":"103","author":"Torres","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-20250503","first-page":"mgen000476","article-title":"Comprehensive genome analyses of Sellimonas intestinalis, a potential biomarker of homeostasis gut recovery.","volume":"6","author":"Munoz","year":"2020","journal-title":"Microb Genom"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/a-1081-2036","article-title":"Exploration of the relationship between gut microbiota and polycystic ovary syndrome (PCOS): a review.","volume":"80","author":"Zhao","year":"2020","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/mSystems.00017-19","article-title":"Probiotic Bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut\u2013brain axis.","volume":"4","author":"Zhang","year":"2019","journal-title":"mSystems"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fmicb.2019.00175","article-title":"Diversity of the gut microbiota in dihydrotestosterone-induced PCOS rats and the pharmacologic effects of diane-35, probiotics, and berberine.","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Microbiol"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/gbe\/evu050","article-title":"A phylogenomic view of ecological specialization in the Lachnospiraceae, a family of digestive tract-associated bacteria.","volume":"6","author":"Meehan","year":"2014","journal-title":"Genome Biol Evol"},{"issue":"sup1","key":"R42-20250503","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1080\/10408398.2018.1542587","article-title":"Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria.","volume":"59","author":"Fu","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity.","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ijo.2014.153","article-title":"The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents.","volume":"39","author":"Psichas","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/07315724.2019.1657515","article-title":"A new approach to polycystic ovary syndrome: the gut microbiota.","volume":"39","author":"Yurtdas","year":"2020","journal-title":"J Am Coll Nutr"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1038\/s41467-022-34502-3","article-title":"Gut microbiome-wide association study of depressive symptoms.","volume":"13","author":"Radjabzadeh","year":"2022","journal-title":"Nat Commun"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.2174\/1381612822666160715143933","article-title":"Gut-brain axis and metabolism in polycystic ovary syndrome.","volume":"22","author":"Saydam","year":"2016","journal-title":"Curr Pharm Des"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.2147\/DMSO.S275898","article-title":"Obesity, insulin resistance, and Type 2 diabetes: associations and therapeutic implications.","volume":"13","author":"Wondmkun","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"112678","DOI":"10.1016\/j.biopha.2022.112678","article-title":"The links between gut microbiota and obesity and obesity related diseases.","volume":"147","author":"Geng","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites.","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.gastro.2013.04.056","article-title":"Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.","volume":"145","author":"Kim","year":"2013","journal-title":"Gastroenterology"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCGENETICS.116.001396","article-title":"Mendelian randomization studies do not support a role for Vitamin D in coronary artery disease.","volume":"9","author":"Manousaki","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"R53-20250503","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","article-title":"Recent developments in Mendelian randomization studies.","volume":"4","author":"Zheng","year":"2017","journal-title":"Curr Epidemiol Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:18:55Z","timestamp":1746317935000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":53,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040115","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}